What is Myomo Price-to-Operating-Cash-Flow?
As of today (2024-05-08), Myomo's share price is $3.575.
Myomo's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.20. Hence, Myomo's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Myomo's Price-to-Operating-Cash-Flow or its related term are showing as below:
Myomo's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $-0.07.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.20.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 57.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 59.70% per year.
During the past 8 years, Myomo's highest 3-Year average Operating Cash Flow per Share Growth Rate was 60.10% per year. The lowest was -7.60% per year. And the median was 57.50% per year.
Myomo Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Myomo's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Myomo Price-to-Operating-Cash-Flow Chart
|
Myomo Annual Data
|
|
Trend |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
- |
- |
- |
- |
|
Myomo Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Myomo's Price-to-Operating-Cash-Flow
For the Medical Devices subindustry, Myomo's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myomo's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Myomo's Price-to-Operating-Cash-Flow falls into.
Myomo Price-to-Operating-Cash-Flow Calculation
Myomo's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 3.575 | / | -0.201 |
| = | |
Myomo's Share Price of today is $3.575.
Myomo's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Myomo (MYO) Business Description
Traded in Other Exchanges
Address
137 Portland Street, 4th Floor, Boston, MA, USA, 02114
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
Executives
| Thomas F Kirk |
director |
|
| Milton Mayo Morris |
director |
2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019 |
| Paul R Gudonis |
director, officer: Chief Executive Officer |
9 HICKORY ROAD, MANCHESTER MA 01944 |
| David A Henry |
officer: Chief Financial Officer |
|
| Harry Kovelman |
officer: Chief Medical Officer |
C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114 |
| Yitzchak Jacobovitz |
director |
MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114 |
| Micah Mitchell |
officer: Chief Commercial Officer |
C/O MYOMO, INC., ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA 02139 |
| Crowley Thomas Aloysius Jr. |
director |
19 ST CLAIR AV, SPRING LAKE NJ 07762 |
| Cliff Conneighton |
officer: Chief Marketing Officer |
53 DEPOT ROAD, HOLLS NH 03049 |
| Jonathan Naft |
officer: VP, General Manager |
C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142 |
| Brandon M Green |
officer: Chief Medical Officer |
C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142 |
| Ralph A Goldwasser |
officer: Chief Financial Officer |
BNN CORP, 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140 |
| Davie Mendelsohn |
officer: VP, Sales |
C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142 |
| Steve Sanghi |
director |
2355 W CHANDLER BLVD, CHANDLER AZ 85224-6199 |
| Amy K. Knapp |
director |
75 N. MOUNTAIN AVE, MONTCLAIR NJ 07042 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MYO has been successfully added to your